Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta

Alakananda Basu1, Haidi Tu

  • 1Department of Molecular Biology and Immunology, Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, TX 76107, USA. abasu@hsc.unt.edu

Insights

Protein kinase C (PKC) and extracellular signal-regulated kinases (ERKs) regulate cisplatin-induced apoptosis. Cisplatin activates ERK1/2 via PKCdelta, suggesting a role in DNA damage response and chemoresistance.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Protein kinase C (PKC) regulates apoptosis.
  • Extracellular signal-regulated kinases (ERKs) are involved in DNA damage response.
  • The relationship between PKC, ERKs, and cisplatin-induced apoptosis requires further elucidation.

Purpose of the Study:

  • To investigate the role of the ERK signaling pathway downstream of PKC in cisplatin-induced apoptosis.
  • To determine the specific PKC isoform involved in this pathway.
  • To explore the implications of this pathway in cisplatin-resistant cells.

Main Methods:

  • Utilized PKC activators (PDBu) and inhibitors (bisindolylmaleimide, Gö 6983, rottlerin) to assess ERK1/2 phosphorylation.
  • Employed MEK inhibitor U0126 to block ERK activation.
  • Investigated cisplatin-induced apoptosis and ERK activation in HeLa and cisplatin-resistant HeLa/CP cells.
  • Used siRNA to deplete PKCdelta and assess its effect on ERK activation.

Main Results:

  • PKC activation by PDBu led to ERK1/2 phosphorylation, inhibited by general PKC inhibitors and U0126.
  • Cisplatin induced concentration-dependent ERK1/2 activation in HeLa cells.
  • ERK2 levels were reduced in cisplatin-resistant HeLa/CP cells.
  • Inhibition of MEK (U0126) or PKCdelta (rottlerin, siRNA) suppressed cisplatin-induced ERK activation and cell death.

Conclusions:

  • Cisplatin-induced DNA damage activates ERK1/2 signaling through PKCdelta.
  • This PKCdelta-ERK pathway plays a crucial role in regulating cisplatin-induced apoptosis.
  • Understanding this pathway may offer insights into overcoming cisplatin resistance.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.